27 November 2025 - Ghent ICC
Karen De Ceunynck | R&D program and strategic partnerships lead
Karen De Ceunynck, PhD, is a biomedical scientist with over a decade of experience advancing innovative therapeutics across academia, biotech, and pharma. Karen earned her PhD from KU Leuven and completed a postdoctoral fellowship at BIDMC/Harvard Medical School in Boston, USA. Following her postdoc, she joined Bioverativ (a Sanofi company) where she co-led a biologics drug discovery program in the rare bleeding disorders group. She then joined a start-up as the biology lead directing preclinical programs in Hemophilia A and Duchenne Muscular dystrophy for a novel non-viral gene therapy platform. After her time at the start-up, she joined the tech transfer office for a university in Cambridge, USA, as an Associate Director Alliance management. There she managed strategic research partnerships between university faculty and industry partners.
| For job seekers | For employers | Join BCF Career Event |
| | Register BCF BE | |
| Powered by: Hyphen Projects Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 |
© Copyright 2025 by Hyphen Projects